You are here: Industry Insights > antibiotic

News List

Link between early antibiotic exposure and weight gain in young children europeanpharmaceuticalreview
November 05, 2018
A recent study has shown that antibiotics use in young children (under 24 months) could result in weight gain shown when the child reaches the age of 5…
Manchester team develops non-antibiotic drug against TB biospectrumasia
October 15, 2018
The team hopes that the compound developed after 10 years of painstaking research will be tried on humans within three to four years.
Antibiotic for skin condition granted Priority Review by FDA europeanpharmaceuticalreview
September 07, 2018
The US FDA have granted the NDA for iclaprim, an antibiotic for a skin condition, Priority Review, with a decision date set for February 2019…
US researchers find 8,000 new antibiotic combinations effective pharmaceutical-technology
September 06, 2018
Researchers at the University of California, Los Angeles (UCLA) have discovered that nearly 8,000 four and five-antibiotic combinations are more effective at treating their indicated conditions than previously thought.
AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3 fiercebiotech
August 21, 2018
Entasis Therapeutics has filed to raise up to $86 million through an IPO. The AstraZeneca spinout is seeking the money to fund a phase 3 trial of a drug to overcome bacterial resistance to beta-lactams.
Achaogen wields ax on R&D, C-suite as antibiotic launch gets underway fiercepharma
July 30, 2018
The impact of Achaogen’s narrower-than-expected label for antibiotic Zemdri is now apparent: The biotech has slashed 28% of its staff and all but two R&D programs.
Antibiotic supply chains on 'brink of collapse' pharmatimes
July 06, 2018
The Access to Medicine Foundation has warned that antibiotic supply chains are on the brink of collapse, putting basic healthcare at risk.
Nabriva closes in on bringing new class of antibiotic to market pharmafile
May 25, 2018
Nabriva Therapeutics, a biotech based in Dublin, Ireland, has announced positive Phase 3 data for its antibiotic, lefamulin, which could result in a newly approved antibiotic for doctors to utilise – a type of approval that are few and far between.
Rapid Detection of Pathogen and Antibiotic Resistance with DNAe’s LiDia® Bloodstream Infection (BSI) Technology b3cnewswire
April 26, 2018
DNAe, announces new data generated with its LiDia® Bloodstream Infection (BSI) technology, currently in development.
Rapid Detection of Pathogen and Antibiotic Resistance with DNAe’s LiDia® Bloodstream Infection (BSI) Technology b3cnewswire
April 25, 2018
DNAe announces new data generated with its LiDia® Bloodstream Infection (BSI) technology, currently in development.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page